Lex

AstraZeneca's new entrant

AstraZeneca, the Anglo-Swedish pharmaceuticals company, has appointed Pascol Soriot from Roche as its new chief executive. Lex's Stuart Kirk and Vincent Boland look at what the move could mean for the struggling drugs company.